Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Hui Guo

5PUBLICATIONS

3CO-AUTHORS

Molecular targetsAllergyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Dec 14, 2023

Association of lung diseases with coronavirus disease 2019 in cancer patients receiving immune checkpoint inhibitors: A multicenter study during national Omicron outbreak in China.

Yanlin Li, Tongfei Wang, Yamin Zhang

|Jun 08, 2023

Risk factors and immunomodulators use in steroid-refractory checkpoint inhibitor pneumonitis.

Yanlin Li, Xiaohui Jia, Yajuan Zhang

|Mar 09, 2022

First-line chemotherapy plus immune checkpoint inhibitors or bevacizumab in advanced non-squamous non-small-cell lung cancer without <i>EGFR</i> mutations or <i>ALK</i> fusions.

Panpan Jiang, Luying Geng, Ziyang Mao

|Jul 09, 2021

NT157 Inhibits HCC Migration via Downregulating the STAT3/Jab1 Signaling Pathway.

SiZhe Yu, Yu Wang, KeJia Lv

|Apr 03, 2020

Tumor-infiltrating immune cells in hepatocellular carcinoma: Tregs is correlated with poor overall survival.

SiZhe Yu, Yu Wang, Jia Hou

Pageof 1

Frequent Collaborators

1 joint publications

Panpan Jiang

1 joint publications

Luying Geng

1 joint publications

Yu Yao

Frequent Collaborators

1 joint publications

Panpan Jiang

1 joint publications

Luying Geng

1 joint publications

Yu Yao

Top Related Videos

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on : Sep 20, 2024

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

See more related videos

Top Related Videos

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on : Sep 20, 2024

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

See more related videos